• NAT1–ENO1–Lactate Axis in Colorectal Cancer

  2026-09-23

  A 2026 MedComm study identifies a NAT1–ENO1–lactate circuit that connects tumor glycolysis with TRAF6-dependent PD-L1 stabilization in colorectal cancer. Its combination of patient data, multi-omics, biochemical analysis, and mouse models suggests that metabolic-state measurements may help explain variation in checkpoint-blockade responses.

• Ferrostatin-1 (Fer-1): Mechanism and Research Use

  2026-09-22

  Ferrostatin-1, also called Fer-1, is a selective ferroptosis inhibitor that suppresses lipid peroxidation and lipid reactive oxygen species. Its nanomolar cellular benchmark supports ferroptosis assays in cancer biology research, neurodegenerative disease models, and related oxidative injury studies.

• From CTD Phospho-Maps to Cysteine Accessibility

  2026-09-22

  A translational framework connecting RNAPII CTD phosphorylation biology with orthogonal cysteine-accessibility measurements using MTSEA-biotin, while defining what the chemistry can—and cannot—claim in a mechanistic workflow.

• Neticonazole Hydrochloride: Research Workflows

  2026-09-21

  Neticonazole Hydrochloride supports two distinct research paths: validated topical antifungal work and exploratory colorectal cancer studies. This practical guide connects diagnosis, formulation, cell-based assays, exosome analysis, and troubleshooting without overstating preclinical oncology evidence.

• Native PAGE as a Translational Decision Tool

  2026-09-21

  Native protein gel electrophoresis can add a mechanistic layer to iPSC-based disease models by examining charge, conformation, and complex integrity without denaturation. This thought-leadership article explains how the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit (PI ≤ 7.0) can complement phenotype-driven translational research, including cystic fibrosis workflows, while clarifying its scope, limitations, and strategic value.

• Bradykinin B2 Receptors and Ileal Peristalsis

  2026-09-20

  Chan and Rudd showed that bradykinin suppresses the peristaltic reflex in guinea pig isolated ileum through B2, rather than B1, kinin receptors. Their pressure-threshold assay and selective agonist–antagonist design provide a useful framework for separating receptor-specific regulation of intestinal propulsion from direct smooth-muscle effects.

• Disodium Bicinchoninate for Cell Assay Workflows

  2026-09-19

  Disodium bicinchoninate provides an aqueous route for developing copper-dependent biochemical readouts, protein normalization assays, and chelation-focused workflows. Its high water solubility and poor compatibility with common organic solvents make fresh, matrix-matched preparation central to reproducible results.

• ETS1–SENP2 Axis in BPD Mitophagy

  2026-09-18

  The reference study identifies ETS1 as a transcriptional regulator that protects against hyperoxia-associated bronchopulmonary dysplasia by coordinating SENP2, HSPA8, and FUNDC1. Its findings connect SUMO1-dependent control of a mitophagy receptor with chaperone-mediated protein turnover, offering a mechanistic framework for studying mitochondrial quality control in developing lung tissue.

• (+)-Bicuculline: GABAA Protocol Guide

  2026-09-18

  (+)-Bicuculline is a research reagent for controlled blockade of GABAA-mediated inhibition in neuronal assays, with additional dossier-described activity involving SK channels and synaptic NMDA receptor signaling modulation. This guide focuses on solubilization, storage, controls, and interpretation; the compound is for scientific research only and should not be used diagnostically or medically.

• Talabostat Mesylate: DPP4 and FAP Research

  2026-09-17

  Talabostat mesylate, also called PT-100, is an orally active dipeptidyl peptidase inhibitor used to study DPP4 and FAP biology. Research evidence supports FAP-dependent biochemical and cellular activity, while available xenograft findings indicate modest, non-significant tumor-growth effects rather than established anticancer efficacy.

• Z-LEHD-FMK: Mapping Apoptosis Without Confusion

  2026-09-17

  Z-LEHD-FMK is an irreversible caspase-9 inhibitor for dissecting mitochondria-mediated apoptosis. This article explains how to use it as a pathway-mapping tool, particularly when apoptosis must be distinguished from caspase-1-dependent pyroptosis in cancer and neuroprotection studies.

• Trichostatin A (TSA) for HDAC Research

  2026-09-16

  Trichostatin A (TSA) offers reversible HDAC inhibition for connecting histone acetylation with cancer-cell phenotypes, differentiation, and ferroptosis sensitivity. This practical guide translates the HDAC3–NRF2–GPX4 findings into controlled TSA workflows while emphasizing dose design, orthogonal readouts, and troubleshooting.

• MK-8745: Aurora A Inhibitor Workflow

  2026-09-16

  MK-8745 connects potent, selective Aurora A inhibition with measurable mitotic arrest, tetraploidy, and apoptosis in cancer models. This workflow shows how to control solvent handling, p53 context, cell-cycle readouts, and translational extensions from lymphoma and colorectal models to retinoblastoma research.

• From Fluorescent Probes to Translational RNAi

  2026-09-15

  Fluorescent RNA probes can do more than visualize transcripts: they can help translational researchers connect RNA synthesis, delivery, spatial localization, and functional validation. This thought-leadership article examines how tunable Cy3-UTP incorporation and nanocarrier-enabled RNAi studies can inform a more rigorous validation strategy.

• Hydroxyl-Radical Degradation of Dimetridazole in Water

  2026-09-15

  The reference study combines quantum-chemical reaction analysis, kinetics, and toxicity assessment to explain how hydroxyl radicals transform Dimetridazole and ornidazole in aqueous systems. Its central contribution is linking a plausible OH-imidazole degradation pathway and high calculated reaction rates with a warning that early transformation products may be more toxic to aquatic organisms than later products.

8052 records 1/537 page Next 12345 下5页 Last page